- Home
- Publications
- Publication Search
- Publication Details
Title
Arsenic-Mediated Activation of the Nrf2-Keap1 Antioxidant Pathway
Authors
Keywords
-
Journal
JOURNAL OF BIOCHEMICAL AND MOLECULAR TOXICOLOGY
Volume 27, Issue 2, Pages 99-105
Publisher
Wiley
Online
2012-11-28
DOI
10.1002/jbt.21463
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Rat H9c2 cardiac myocytes are sensitive to arsenite due to a modest activation of transcription factor Nrf2
- (2011) Daigo Sumi et al. ARCHIVES OF TOXICOLOGY
- Opposite effects of arsenic trioxide on the Nrf2 pathway in oral squamous cell carcinoma in vitro and in vivo
- (2011) Xinyan Zhang et al. CANCER LETTERS
- Frequent epigenetics inactivation of KEAP1 gene in non-small cell lung cancer
- (2011) Lucia Anna Muscarella et al. Epigenetics
- Microarray analysis revealed dysregulation of multiple genes associated with chemoresistance to As2O3 and increased tumor aggressiveness in a newly established arsenic-resistant ovarian cancer cell line, OVCAR-3/AsR
- (2011) Pei-Shi Ong et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- Inhibition of heme oxygenase-1 enhances anti-cancer effects of arsenic trioxide on glioma cells
- (2011) Yaohua Liu et al. JOURNAL OF NEURO-ONCOLOGY
- Brusatol enhances the efficacy of chemotherapy by inhibiting the Nrf2-mediated defense mechanism
- (2011) D. Ren et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Arsenic Exposure and Toxicology: A Historical Perspective
- (2011) Michael F. Hughes et al. TOXICOLOGICAL SCIENCES
- Arsenic trioxide — An old drug rediscovered
- (2010) Ashkan Emadi et al. BLOOD REVIEWS
- The NRF2-mediated oxidative stress response pathway is associated with tumor cell resistance to arsenic trioxide across the NCI-60 panel
- (2010) Qian Liu et al. BMC Medical Genomics
- High Levels of Nrf2 Determine Chemoresistance in Type II Endometrial Cancer
- (2010) T. Jiang et al. CANCER RESEARCH
- Alpha-lipoic acid regulates heme oxygenase gene expression and nuclear Nrf2 activation as a mechanism of protection against arsenic exposure in HepG2 cells
- (2010) Selene G. Huerta-Olvera et al. ENVIRONMENTAL TOXICOLOGY AND PHARMACOLOGY
- p62/SQSTM1Is a Target Gene for Transcription Factor NRF2 and Creates a Positive Feedback Loop by Inducing Antioxidant Response Element-driven Gene Transcription
- (2010) Ashish Jain et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Ubiquitin accumulation in autophagy-deficient mice is dependent on the Nrf2-mediated stress response pathway: a potential role for protein aggregation in autophagic substrate selection
- (2010) Brigit E. Riley et al. JOURNAL OF CELL BIOLOGY
- Reduction of arsenic-induced cytotoxicity through Nrf2/HO-1 signaling in HepG2 cells
- (2010) Yumi Abiko et al. JOURNAL OF TOXICOLOGICAL SCIENCES
- A Noncanonical Mechanism of Nrf2 Activation by Autophagy Deficiency: Direct Interaction between Keap1 and p62
- (2010) A. Lau et al. MOLECULAR AND CELLULAR BIOLOGY
- Loss of Kelch-Like ECH-Associated Protein 1 Function in Prostate Cancer Cells Causes Chemoresistance and Radioresistance and Promotes Tumor Growth
- (2010) P. Zhang et al. MOLECULAR CANCER THERAPEUTICS
- The Cinnamon-Derived Dietary Factor Cinnamic Aldehyde Activates the Nrf2-Dependent Antioxidant Response in Human Epithelial Colon Cells
- (2010) Georg Wondrak et al. MOLECULES
- Keap1 perceives stress via three sensors for the endogenous signaling molecules nitric oxide, zinc, and alkenals
- (2010) M. McMahon et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Putative chemopreventive molecules can increase Nrf2-regulated cell defense in some human cancer cell lines, resulting in resistance to common cytotoxic therapies
- (2009) Liangao Hu et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Nrf2: friend or foe for chemoprevention?
- (2009) T. W. Kensler et al. CARCINOGENESIS
- Oral exposure to inorganic arsenic: evaluation of its carcinogenic and non-carcinogenic effects
- (2009) Ulrike Schuhmacher–Wolz et al. CRITICAL REVIEWS IN TOXICOLOGY
- Acquisition of doxorubicin resistance in ovarian carcinoma cells accompanies activation of the NRF2 pathway
- (2009) Gi-seong Shim et al. FREE RADICAL BIOLOGY AND MEDICINE
- Reactive Oxygen Species Are Not Required for an Arsenic Trioxide-induced Antioxidant Response or Apoptosis
- (2009) Alejo A. Morales et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Biological Responses to Arsenic Compounds
- (2009) Leonidas C. Platanias JOURNAL OF BIOLOGICAL CHEMISTRY
- Oncogenic NRF2 mutations in squamous cell carcinomas of oesophagus and skin
- (2009) Yoo Ri Kim et al. JOURNAL OF PATHOLOGY
- Critical Cysteine Residues of Kelch-Like ECH-Associated Protein 1 in Arsenic Sensing and Suppression of Nuclear Factor Erythroid 2-Related Factor 2
- (2009) X. He et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Darinaparsin induces a unique cellular response and is active in an arsenic trioxide-resistant myeloma cell line
- (2009) S. M. Matulis et al. MOLECULAR CANCER THERAPEUTICS
- NRF2 Cysteine Residues Are Critical for Oxidant/Electrophile-Sensing, Kelch-Like ECH-Associated Protein-1-Dependent Ubiquitination-Proteasomal Degradation, and Transcription Activation
- (2009) X. He et al. MOLECULAR PHARMACOLOGY
- Nrf2 protects against As(III)-induced damage in mouse liver and bladder
- (2009) Tao Jiang et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
- Loss of Keap1 Function Activates Nrf2 and Provides Advantages for Lung Cancer Cell Growth
- (2008) T. Ohta et al. CANCER RESEARCH
- Nrf2 enhances resistance of cancer cells to chemotherapeutic drugs, the dark side of Nrf2
- (2008) X.-J. Wang et al. CARCINOGENESIS
- Oridonin Confers Protection against Arsenic-Induced Toxicity through Activation of the Nrf2-Mediated Defensive Response
- (2008) Yu Du et al. ENVIRONMENTAL HEALTH PERSPECTIVES
- Arsenic-induced malignant transformation of human keratinocytes: Involvement of Nrf2
- (2008) Jingbo Pi et al. FREE RADICAL BIOLOGY AND MEDICINE
- Genetic Alteration of Keap1 Confers Constitutive Nrf2 Activation and Resistance to Chemotherapy in Gallbladder Cancer
- (2008) Tatsuhiro Shibata et al. GASTROENTEROLOGY
- Molecular mechanisms of Nrf2-mediated antioxidant response
- (2008) Wenge Li et al. MOLECULAR CARCINOGENESIS
- Dual roles of Nrf2 in cancer
- (2008) A LAU et al. PHARMACOLOGICAL RESEARCH
- Cancer related mutations in NRF2 impair its recognition by Keap1-Cul3 E3 ligase and promote malignancy
- (2008) T. Shibata et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Activation of Nrf2 by arsenite and monomethylarsonous acid is independent of Keap1-C151: enhanced Keap1–Cul3 interaction
- (2008) Xiao-Jun Wang et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started